Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

48.70 +1.09 (+2.30%)
Streaming Delayed Price Updated: 1:28 PM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,584,288
Open 48.10
Bid (Size) 48.70 (400)
Ask (Size) 48.71 (600)
Prev. Close 47.61
Today's Range 47.98 - 48.80
52wk Range 43.08 - 109.04
Shares Outstanding N/A
Dividend Yield 4.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Prediction: 1 Healthcare Giant Set to Soar in 2026 ↗
Novo Nordisk has struggled this past year, but its beaten-down valuation has made it a bargain buy today. 
Via The Motley Fool
Topics ETFs
News headline image
The Weight of a Trillion: Inside Eli Lilly’s Pharmaceutical Hegemony
On this day in late 2025, Eli Lilly and Company (NYSE: LLY) stands as the undisputed titan of the global pharmaceutical industry. Having crossed the historic $1 trillion market capitalization threshold... 
Via PredictStreet
Topics Economy World Trade

Performance

YTD
-44.3%
-44.3%
1 Month
+2.4%
+2.4%
3 Month
-21.3%
-21.3%
6 Month
-34.0%
-34.0%
1 Year
-54.0%
-54.0%

More News

Read More
News headline image
Better Buy in 2026: Novo Nordisk or Intuitive Surgical? ↗
Via The Motley Fool
News headline image
Better Pharmaceutical Buy: Eli Lilly vs. Novo Nordisk ↗
Via The Motley Fool
The 2025 Weight-Loss Drug Gold Rush: How Eli Lilly Pulled Ahead, Novo Hit A Snag — And A Swarm Of Biotech Underdogs Are Closing In ↗
Via Stocktwits
Why Did Structure Therapeutics Stock Surge Pre-Market Today? ↗
Via Stocktwits
News headline image
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
Via MarketMinute
Topics Intellectual Property
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
From USA News Group
Via GlobeNewswire
News headline image
Profit Powerhouse: Strong Earnings Outlook Defies Market Slips, Signaling Continued Bull Run for US Stocks
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Pfizer Adds to Its Big Bet on Weight Loss Drugs ↗
Via MarketBeat
News headline image
Eli Lilly Just Delivered Fantastic News to Investors ↗
Via The Motley Fool
News headline image
2 Predictions for Novo Nordisk in 2026 ↗
Via The Motley Fool
News headline image
My Top 10 Stocks to Buy for 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Novo Nordisk Stock Topped the Market on Thursday ↗
Via The Motley Fool
News headline image
Navigating Nuance: Tech Innovation, Healthcare Revival, and Energy's Evolving Landscape Shape Late 2025 Markets
Via MarketMinute
Topics Artificial Intelligence Economy Electric Vehicles
News headline image
Novo Nordisk (NVO) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Eli Lilly's Retatrutide Soars: Unprecedented Trial Results Propel Pharma Giant, Ignite Obesity Market
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Golden Cross Alert: 3 Stocks With Major Upside Potential ↗
Via MarketBeat
News headline image
Warning: This Skyrocketing Stock Has a Hidden Risk ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Absurdly Cheap Stocks That Look Like Steals Right Now ↗
Via The Motley Fool
Topics Economy World Trade
News headline image
Why Wave Life Sciences Stock Crushed it Again Today ↗
Via The Motley Fool
News headline image
Prediction: This Surprising Growth Stock Will Reach -- and Stay in -- the Trillion-Dollar Club in 2026. ↗
Via The Motley Fool
News headline image
5 High Short-Interest Stocks to Buy Before Q1 2026 ↗
Via MarketBeat
News headline image
Why Wave Life Sciences Stock Vaulted 146% Higher on Monday ↗
Via The Motley Fool
News headline image
Why Novo Nordisk Stock Was Melting on Monday ↗
Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 48.70
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 12/19/25 01:28 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.